Cellebrite DI (CLBT)
Statistics
| Metric | Value |
|---|---|
| Last Close | $12.71 |
| Blended Price Target | 15.43 |
| Blended Margin of Safety | 21.4% Undervalued |
| Rule of 40 (Next) | 49.5% |
| Rule of 40 (Current) | 51.7% |
| FCF-ROIC | 32.7% |
| Sales Growth Next Year | 16.7% |
| Sales Growth Current Year | 19.0% |
| Sales 3-Year Avg | 19.4% |
| Industry | Software - Infrastructure |
Analysis
Cellebrite DI stands out as a durable business with a robust platform that extracts and analyzes digital evidence for law enforcement and intelligence agencies worldwide. Its revenue growth outlook remains strong, fueled by a shift to high-recurrence subscriptions that now dominate its model, providing predictable cash flows even amid federal spending headwinds.[1][4] The economic moat, built on proprietary technology for unlocking diverse devices and high switching costs for mission-critical users, protects margins and supports ongoing expansion into cloud-based SaaS offerings.
Leadership under CEO Yossi Carmil demonstrates disciplined execution, blending organic growth with strategic acquisitions like Corellium to broaden capabilities across investigations from child exploitation to financial crimes.[1] This combination yields a high-quality operation: recurring revenues ensure stability, a widening moat via technological leadership fortifies defensibility, and proven capital allocation sustains above-market growth for years ahead. Cellebrite's focus on public safety tailwinds positions it as a resilient leader in digital forensics.
What the Company Does
Cellebrite DI develops software solutions that help law enforcement, government agencies, and enterprises access, extract, analyze, and manage digital evidence from mobile devices and cloud sources. Its platform supports investigations into crimes like human trafficking, terrorism, and cryptocurrency fraud by unlocking phones, decoding data, and sharing insights securely across the investigative lifecycle.[3]
Revenue primarily comes from subscriptions, which reached about 90% of total sales in recent periods, with the rest from professional services and one-time licenses.[1][4] Annual Recurring Revenue (ARR) stood at $480.8 million for full-year 2025, reflecting strong demand for its SaaS and cloud-enabled tools.[1]
Revenue Recurrence & Predictability
Cellebrite's revenue is overwhelmingly subscription-based, with over 90% now recurring from multi-year contracts for its flagship platform.[1][4] This shift from transactional licenses to SaaS models has boosted predictability, as evidenced by 21% ARR growth to $480.8 million in 2025 despite U.S. federal budget challenges.[1]
The company scores highly on this criterion, with subscription revenue hitting $115.5 million in Q4 2025 alone, up 21% year-over-year.[1] High renewal rates and expanding contracts with public sector clients make cash flows reliable, minimizing lumpiness from project work.
Revenue Growth Durability
Cellebrite can sustain above-market growth for at least the next 3-5 years by penetrating a vast total addressable market in digital forensics, driven by rising device complexity and global crime trends. Key levers include SaaS adoption, geographic expansion, and upselling premium features to existing customers, with organic ARR up 17% excluding the Corellium acquisition.[1]
Structural tailwinds like increasing mobile data in investigations and cloud authorizations outweigh headwinds such as temporary U.S. federal delays, setting up reacceleration in 2026.[1][5] Low penetration in emerging markets and enterprise segments provides ample runway.
Economic Moat
Cellebrite's moat stems from its proprietary algorithms for unlocking a wide range of OEM devices, creating high switching costs for agencies reliant on its platform for time-sensitive cases. Intangible assets like decades of forensic expertise and regulatory compliance give it an edge over smaller rivals.[3][6]
The moat is widening through network effects in its ecosystem—more users improve data sharing and analytics—and cost advantages from scale in R&D for evolving encryption. Acquisitions like Corellium enhance virtual device testing, solidifying leadership without easy replication.[1]
Management & Leadership
Cellebrite is not founder-led; CEO Yossi Carmil, appointed in 2021, has a strong track record of steering the subscription transition and delivering consistent ARR growth amid macroeconomic pressures.[1][5]
Insider ownership aligns interests, and capital allocation shines in tuck-in buys like Corellium, which added capabilities without derailing profitability. The team emphasizes efficiency, targeting 30%+ free cash flow margins into 2026.[1]
Key Risks
Customer concentration poses a threat, as reliance on U.S. federal and state agencies exposes results to budget cycles; 2025 growth slowed partly from federal spending freezes, though diversification into international and enterprise markets mitigates this.[1][5]
Regulatory scrutiny in digital privacy could intensify, especially with expanding cloud tools and global operations, potentially delaying approvals or limiting features in key regions.[3] Technological risks loom from phone makers like Apple enhancing encryption, demanding relentless R&D to maintain unlock rates.[6]
Operational challenges include integration of acquisitions like Corellium, where execution slips could dilute focus on core forensics.[1]
Sources
- https://investors.cellebrite.com/news-releases/news-release-details/cellebrite-announces-record-fourth-quarter-and-full-year-2025
- https://stockanalysis.com/stocks/clbt/revenue/
- https://simplywall.st/stocks/us/software/nasdaq-clbt/cellebrite-di
- https://simplywall.st/stocks/us/software/nasdaq-clbt/cellebrite-di/news/assessing-cellebrite-di-clbt-valuation-after-its-spring-2026
- https://investors.cellebrite.com/news-releases/news-release-details/cellebrite-announces-third-quarter-2025-results/
- https://investors.cellebrite.com/static-files/288697a6-803a-43c8-8d26-e5a07aad9f92
- https://freedom24.com/ideas/details/17559
- https://www.marketbeat.com/earnings/reports/2026-5-13-cellebrite-di-ltd-stock/